Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable of reaching targets beyond the liver. The Japanese drugmaker is best ...

Vigilantes serves as a prequel/spin-off to the main MHA series, featuring new characters and stories while still connecting to the original. Vigilantes can be a great starting point for new MHA ...

Dai-ichi Life Holdings (DCNSF – Research Report) received a Hold rating and a Yen4,900.00 price target from Jefferies analyst Sam Wong on March 7. The company’s shares closed last Friday at ...

Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally. The company offers Enhertu to treat patients with HER2 positive ...

(Bloomberg) -- Dai-ichi Life Holdings Inc. said a US subsidiary agreed to transfer insurance blocks totaling about $9.7 billion in policy reserves to a reinsurance firm to improve earnings. Protective ...

Feb 28 (Reuters) - The European Union's health regulator on Friday backed AstraZeneca (AZN.L), opens new tab and Daiichi Sankyo's (4568.T), opens new tab drug Enhertu as a breast cancer treatment ...

Curse is a dark dungeon RPG centered around the concept of curses. The player takes on the role of an adventurer tasked with saving a town plagued by a curse, while exploring dungeons filled with ...

Just over a decade after being acquired by Daiichi Sankyo, US biotech Plexxikon will be shuttered at the end of March, with its R&D projects transferred to other areas of the Japanese group. It's ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...

My Hero Academia: You're Next heading to digital platforms for fans to buy or rent. The film was a success, grossing over $32 million worldwide. 2025 will bring the final season of My Hero ...

Three main themes emerged. (1) A predominant unmet need was how to manage the profound fear of recurrence and anxiety post-treatment. Survivors desired more information about signs and symptoms of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...